We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Honey on Xerostomia and Oral Mucositis (AC-H)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01465308
First Posted: November 4, 2011
Last Update Posted: October 8, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Dr. Andreas Charalambous, Cyprus University of Technology
  Purpose
The purpose of this study is to determine whether the use of pure honey will help in the treatment of radiation induced xerostomia and oral mucositis (symptom management)

Condition Intervention Phase
Head and Neck Cancer Dietary Supplement: Honey mouthwash Other: Normal Saline Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: A Randomized Control Trial for the Effect of Honey on Radiotherapy Induced Xerostomia and Oral Mucositis in Patients With Head and Neck Cancers

Resource links provided by NLM:


Further study details as provided by Dr. Andreas Charalambous, Cyprus University of Technology:

Primary Outcome Measures:
  • Change from baseline in Xerostomia grades [ Time Frame: 1 week, 2 weeks, 3 weeks, 4 weeks ]
  • Change from baseline in oral mucositis grades [ Time Frame: 1 week, 2 weeks, 3 weeks, 4 weeks ]

Secondary Outcome Measures:
  • Changes in the General satisfaction of comfort [ Time Frame: 1 week, 2 week, 3 week, 4 week ]
  • Change in baseline weight in one month [ Time Frame: 4 weeks ]

Enrollment: 72
Study Start Date: August 2011
Study Completion Date: October 2014
Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: receiving Honey
The patients will receive honey mouthwash rinses
Dietary Supplement: Honey mouthwash
The patients in the intervention group will receive honey mouthwash 15 minutes before the radiotherapy session, 15 minutes after and 6 hours after the radiotherapy session
Active Comparator: Saline mouthwash
The patients in this group will receive saline rinses
Other: Normal Saline
Saline rinses 15 minutes before radiotherapy, 15 minutes after, and 6 hours after radiotherapy

Detailed Description:
Radiation-induced mucositis is a normal acute side effect of radiotherapy treatment. Exposure of ionising radiation to oral, pharyngeal and laryngeal mucosa gives rise to radiation epithelitis towards the second and third weeks of conventional fractionated radiotherapy. Likewise, salivary flow may decrease by approximately 50% during the first week of radiotherapy and upwards of 80% by the seventh week of treatment. Acute radiation-induced xerostomia is associated with inflammatory reaction. The study will include an intervention and a control group, one receiving honey prior and after the radiotherapy and the other group not receiving honey at all.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients who receive radiotherapy (RT) to the oral cavity will be included in the study.
  • Patients with a confirmed histologic diagnosis of head and neck cancer referred to non-palliative radiotherapy will enter into this trial.
  • aged over 18
  • receiving radiotherapy for at least four weeks

Exclusion Criteria:

  • Allergic to honey
  • confirmed and medically treated diabetes mellitus
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01465308


Locations
Cyprus
Bank of Cyprus Oncology Centre
Nicosia, Cyprus, 2006
Sponsors and Collaborators
Cyprus University of Technology
Investigators
Principal Investigator: Andreas Charalambous, PhD Cyprus University of Technology
  More Information

Responsible Party: Dr. Andreas Charalambous, Lecturer-Researcher, Cyprus University of Technology
ClinicalTrials.gov Identifier: NCT01465308     History of Changes
Other Study ID Numbers: AC-HANHS-86
First Submitted: October 31, 2011
First Posted: November 4, 2011
Last Update Posted: October 8, 2014
Last Verified: October 2014

Keywords provided by Dr. Andreas Charalambous, Cyprus University of Technology:
head and neck cancer
radiotherapy induced xerostomia
radiotherapy induced oral mucositis
RCT
symptom management

Additional relevant MeSH terms:
Head and Neck Neoplasms
Mucositis
Stomatitis
Xerostomia
Neoplasms by Site
Neoplasms
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Mouth Diseases
Stomatognathic Diseases
Salivary Gland Diseases